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Abstract
Background: Nationwide surveys have shown a threefold increase in general practitioner (GP) consultations for tick
bites and early Lyme borreliosis from 1994 to 2009 in the Netherlands. We now report an update on 2014, with
identical methods as for the preceding GP surveys.
Methods: To all GPs in the Netherlands, a postal questionnaire was sent inquiring about the number of
consultations for tick bites and erythema migrans diagnoses (most common manifestation of early Lyme borreliosis)
in 2014, and the size of their practice populations.
Results: Contrasting to the previously rising incidence of consultations for tick bites between 1994 and 2009,
the incidence decreased in 2014 to 488 consultations for tick bites per 100,000 inhabitants, i.e., 82,000 patients
nationwide. This survey revealed a first sign of stabilization of the previously rising trend in GP diagnosed erythema
migrans, with 140 diagnoses per 100,000 inhabitants of the Netherlands. This equals about 23,500 annual diagnoses
of erythema migrans nationwide in 2014.
Conclusions: In contrast to the constantly rising incidence of GP consultations for tick bites and erythema migrans
diagnoses in the Netherlands between 1994 and 2009, the current survey of 2014 showed a first sign of
stabilization of erythema migrans diagnoses and a decreased incidence for tick bite consultations.
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Background
Lyme borreliosis is an infectious disease caused by the
bacterium Borrelia (B.) burgdorferi sensu lato and is
transmitted through the bite of infected ticks, mainly
Ixodes ricinus ticks in Europe. Early localised infection is
typically manifested as erythema migrans, a slowly
expanding red or bluish-red skin lesion that is clinically
diagnosed and generally treated successfully with oral
antibiotics [1]. If the diameter of the lesion is less than
five centimetre, the clinical diagnosis of erythema
migrans requires a history of tick-bite, a delay in appear-
ance after the tick bite of at least two days, and an
expanding rash at the site of the tick-bite. If left un-
treated, disseminated Lyme borreliosis can develop (e.g.,
Lyme neuroborreliosis or Lyme arthritis) [1], causing a
considerably larger disease burden [2]. Of the various
clinical presentations of Lyme borreliosis, erythema
migrans is the most common, accounting for about 60
to 95 % of diagnosed Lyme borreliosis in Europe [3–8].
In the Netherlands, the relative proportions for Lyme
borreliosis diagnoses in 2010 were 91 % erythema
migrans, 5.3 % disseminated Lyme borreliosis (mainly
Lyme arthritis 2.1 %, Lyme neuroborreliosis 1.8 %, and
acrodermatitis chronica atrophicans 0.8 %), and 3.8 %
persisting symptoms that were attributed to Lyme
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borreliosis [8]. Periodic nationwide cross-sectional retro-
spective studies among general practitioners (GPs) have
shown a continuing and strong increase in GP consulta-
tions for tick bites and early Lyme borreliosis (measured
as erythema migrans diagnoses) between 1994 and 2009
in the Netherlands [9–12]. A threefold increase was ob-
served for the incidence of tick bite consultations from
191 per 100,000 in 1994 to 564 per 100,000 inhabitants
in 2009, and concurrently the incidence of erythema
migrans diagnoses increased from 39 to 134 per 100,000
inhabitants [9, 12]. Increases of Lyme borreliosis during
the past decades have also been reported from other
European countries [13] and from the North American
continent [14, 15]. Possible explanations for these in-
creases in the Netherlands are changes in the landscape
that may have provided favourable conditions for ticks,
bringing their habitat closer to humans, and increased
total numbers of Ixodes ricinus ticks infected with B.
burgdorferi sensu lato in the Netherlands, possibly due
to increased abundance of wildlife hosts [16]. We cur-
rently report an update on the incidence of GP consulta-
tions for tick bites and erythema migrans diagnoses in
2014, assessed with identical methods as the preceding
GP surveys for 1994, 2001, 2005 and 2009 [9, 12].
Methods
In December 2014, all 10,250 GPs in our country were
asked to complete a brief postal questionnaire, and in
January 2015 reminders were sent to non-responding
GPs. With pre-coded response categories, the question-
naire inquired about the number of consultations for
tick bites and diagnoses of erythema migrans in 2014,
and the size of their practice population. Values were
assigned to the pre-coded response categories, based on
the best fit of an assumed underlying negative binomial
distribution. As every person in the Netherlands is regis-
tered with only one GP, the GP practice populations
were used to calculate incidence rates per 100,000 and
total numbers among the 16.8 million inhabitants of the
Netherlands in 2014. Bootstrap analysis (10,000 resam-
plings of the GP reports) was used to calculate 95 %
confidence intervals (95%CI) for the incidence rates.
Two point estimates with just non-overlapping 95%CI
are a conservative estimate of being different at the 0.05
level of statistical significance. More extensive method
descriptions can be found in publications on preceding
GP surveys [9, 12]. Ethical approval was not required for
this study, because the Medical Research Involving
Human Subjects Act does not apply to this type of
study, collecting physician-reported counts of patients
diagnosed with Lyme borreliosis and counts of tick bite
consultations. To examine a possible bias of our point
estimates through declining GP response over the survey
years, we compared incidence estimates for tick bite
consultations and erythema migrans diagnoses, stratified
for the GP practices that responded to 1–2, 3–4, or all 5
of our GP surveys. We also compared predicted inci-
dence estimates for tick bite consultations and erythema
migrans for a population coverage of 60, 75 and 90 %.
We did so for each survey year independently, with a
simple regression model, using for each municipality the
number of reported erythema migrans diagnoses (or tick
bite consultations), the patient population covered by
the reporting practices as offset and the response being
the fraction of the municipality population covered by
the reporting practices.
To explore a possible relation between the dynamics
in Ixodes ricinus populations in the Netherlands and the
dynamics of GP consultations for tick bites and ery-
thema migrans diagnoses, we included an additional
analysis on changes in tick collections from the field be-
tween 2009 and 2014. In 2006, Wageningen University
started a long-term tick monitoring program in the
context of the Dutch phenological network “Nature’s
Calendar”. Ticks were collected by groups of trained
volunteers at 12 fixed forest plots of 200 square meters
each distributed across the country [17]. From 2006 to
the present, ticks have been collected in the first seven
days of each month, year round. The T-test was applied
for comparison of the average annual numbers of Ixodes
ricinus (larvae, nymphs and adults, averages calculated
separately for each life stage) per field site per month.
All ticks were recounted and identified to species and
life stage by specialists at Wageningen University [17].
Results
Figure 1 shows the incidence rates for GP consultations
for tick bites and erythema migrans diagnoses in 2014,
together with incidence rates from the preceding
surveys. The four identical GP surveys of 1994 to 2009
show a continuously rising trend in consultations for
tick bites and erythema migrans diagnoses. In 2014 the
incidence of GP consultations for tick bites was 488 (95 %
CI 473–503) per 100,000 inhabitants of the Netherlands,
showing a decreased incidence for the first time since the
start of these identical GP surveys in 1994. In 2014 we ob-
served a further rise of the incidence of erythema migrans
diagnoses to 140 (95%CI 135–144) per 100,000 inhabi-
tants of the Netherlands, although the slope of the in-
crease has decreased between 2009 and 2014. As the 95 %
CI of the incidence rates in 2009 and 2014 overlap, these
point estimates cannot be considered to be significantly
different. All GPs nationwide saw approximately 82,000
patients with tick bites and 23,500 patients with erythema
migrans in 2014. Figure 2 shows the geographical distribu-
tion of the incidence of erythema migrans diagnoses in
2014 compared to the preceding GP survey of 2009 [12].
The largest increase of erythema migrans incidence was
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observed in the Northeast of the Netherlands, and several
locations along the West coast.
4203 GPs responded to our postal questionnaire com-
prising a practice population of 10.5 million persons,
which covers 62 % of the 16.8 million inhabitants of the
Netherlands in 2014. Table 1 shows the population
coverage and incidence rates for GP-diagnosed erythema
migrans in the identical surveys from 1994 to 2014.
Compared to the mean incidence estimates for the
whole of the Netherlands, incidence rates for erythema
migrans diagnoses (see Table 1) and consultations for
tick bites (not shown) did not differ substantially, nor
with statistical significance, among the GP practices that
responded to 1–2, 3–4, or all 5 GP surveys. However,
among the GP practices that responded to all 5 GP sur-
veys, the increasing trend in erythema migrans incidence
is stronger between 2009 (132 per 100,000) and 2014
(151 per 100,000), with non-overlapping 95 % CI. The
predicted incidence rates with population coverage set at
60 %, 75 % or 90 % also did not differ substantially, or
with statistical significance, compared to the mean inci-
dence estimates for the whole of the Netherlands. The
predicted incidence rates for erythema migrans with
population coverage set at 60, 75 or 90 % each showed a
rising incidence with non-overlapping 95 % CI between
1994 and 2009, and a stabilizing incidence of erythema
migrans in 2014, as was observed with the mean inci-
dence estimates. With lower population coverage, our
model predicted slightly lower incidence rates. So the
decline in population coverage over the years probably
did not measurably bias our incidence estimates, if yet,
only the 95 % CI around the estimate have slightly
broadened (see Fig. 1).
In the long-term tick monitoring program of the
Wageningen University, no statistically significant in-
creases or decreases were observed in the average annual
numbers of Ixodes ricinus (larvae, nymphs and adults,
averages calculated separately for each life stage) col-
lected monthly at the 12 field sites between 2009 and
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Fig. 1 Incidence of general practitioner (GP) consultations for tick
bites (left Y-axis) and erythema migrans diagnoses (right Y-axis) per
100,000 inhabitants of the Netherlands between 1994 and 2014.
Point estimates with just non-overlapping 95 % confidence intervals
(represented by the vertical bars) are a conservative estimate of
being different at the 0.05 level of statistical significance
Fig. 2 The geographical distribution of the number of GP-diagnosed erythema migrans per 100,000 inhabitants of the Netherlands in 2009 [12]
and 2014
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site per month was 231 in 2014, which was 7 % higher
compared to 217 in 2009 (difference not statistically sig-
nificant). The average annual number of adult ticks per
field site per month was 31 in 2014, which was 11 %
higher compared to 28 in 2009 (difference not statisti-
cally significant).
Discussion & conclusion
In contrast to the constantly rising incidence of GP con-
sultations for tick bites and erythema migrans diagnoses
between 1994 and 2009, we have currently observed a
first sign of stabilization of erythema migrans diagnoses
and a decreased incidence for tick bite consultations in
2014. Possibly, this decrease may have started earlier
after 2009, as incidence rates for tick bite consultations
and erythema migrans diagnoses similar to the incidence
rates in 2014 have already been reported for 2010 [8].
The 2010 incidence rates for tick bite consultations and
erythema migrans diagnoses were 495 (95 % CI 478–512)
and 132 (95 % CI 127–136) per 100,000 respectively, as
obtained in a nationwide cross-sectional retrospective sur-
vey among physicians, using an extended questionnaire
on all Lyme borreliosis manifestations, with comparable
methods to the current GP survey [8]. Based on relative
proportions for Lyme borreliosis diagnoses in the
Netherlands [8], the currently observed 23,500 erythema
migrans diagnoses likely indicate an additional 1400 diag-
noses with disseminated Lyme borreliosis, plus 1000 pa-
tients with Lyme-related persisting symptoms, resulting in
a total of 25,800 cases with diagnosed Lyme borreliosis in
2014. Based on a previous study in which we compared
the GP reports from 2005 to tick bites reported by the
general population of the Netherlands, we observe one
tick bite consultation for approximately every thirteen tick
bites among the general population of the Netherlands
(ratio 7.8 %) and we observe one GP-diagnosed erythema
migrans for approximately every sixty tick bites among
the general population of the Netherlands (1.8 %) [12].
This ratio for tick bites among the general population
versus erythema migrans diagnoses is comparable to the
risk estimates for developing erythema migrans after tick
bites as observed in prospective studies [18–20].
During the past decades, increases of Lyme borreliosis
have been reported from European countries such as
the United Kingdom, the Czech Republic and Hungary
[21–23]. In Germany, the direct Eastern neighbour of the
Netherland, the incidence of Lyme borreliosis increased
between 2001 and 2006, and stabilized between 2009 and
2012 [7, 24]. South to the Netherlands, in Belgium and
France incidence rates for Lyme borreliosis remained
stable between 2003 and 2012 [3, 25, 26].
The greatest increase in erythema migrans incidence
was observed in the Northeast of the Netherlands and
several locations along the West coast, between 2009
and 2014 (Fig. 2) as was seen between 1994 and 2009
[12]. This geographical distribution of high incidence
regions for erythema migrans diagnoses is strongly cor-
related with tick presence as predicted through environ-
mental risk mapping [27]. Geographically focal increases
in erythema migrans incidence could be due to increases
in the risk of infection with B. burgdorferi sensu lato
after tick bites, or specifically B. afzelii which is mostly
associated with skin manifestations such as erythema
migrans and acrodermatitis chronica atrophicans [28].
However, there is no evidence for rising prevalence of B.
burgdorferi sensu lato in ticks, based on combined ana-
lysis of two large field studies [16]: one longitudinal
series of tick collections between 2000 and 2009 in a
coastal dune area [29], and the long-term tick monitor-
ing program of Wageningen University geographically
spread throughout the Netherlands between 2006 and
2009 [17].
For the first time since the start of our identical GP
surveys in 1994, we have currently observed a decreased
incidence for tick bite consultations. Our analyses of the
average annual numbers of ticks per field site per month
Table 1 Annual incidence of erythema migrans (EM) diagnoses per 100,000 inhabitants of the Netherlands for each survey year,
predicted for varying response rates, and stratified for the GP practices that responded to 1 to 2, 3 to 4, or all 5 of our GP surveys
Survey year 1994 2001 2005 2009 2014
% Population coverage 88 % 68 % 71 % 65 % 62 %
Mean incidence of EM 38.6 (37.2–40.0) 74.3 (72.0–76.6) 103.8 (101.0–106.6) 133.9 (130.5–137.5) 139.6 (135.3–144.1)
Incidence of EM (and 95 % CI) per number of GP practices responding to 1 to 5 surveys:
1 to 2 surveys 39.0 (36.7–41.4) 72.3 (66.9–78.1) 112.9 (102.6–123.8) 131.7 (124.8–138.8) 133.7 (127.5–140.2)
3 to 4 surveys 38.3 (35.8–40.9) 77.9 (74.6–81.2) 102.0 (89.3–105.9) 136.6 (131.0–142.3) 137.7 (130.2–145.8)
5 surveys 38.5 (36.2–40.8) 73.0 (69.2–77.2) 104.0 (99.4–109.0) 132.3 (126.3–138.4) 150.6 (141.5–160.1)
Incidence of EM (and 95 % CI) among municipalities with population coverage:
60 % coverage 40.2 (32.5–49.0) 73.0 (67.6–78.8) 99.6 (91.4–108.8) 132.3 (123.5–142.7) 139.8 (129.1–152.0)
75 % coverage 39.5 (35.2–44.6) 76.3 (71.2–81.8) 104.5 (98.4–111.1) 135.7 (127.6–144.7) 141.0 (131.5–151.8)
90 % coverage 38.8 (36.4–41.5) 79.5 (71.2–88.5) 109.5 (101.2–118.0) 139.0 (127.8–150.7) 142.1 (129.7–155.9)
Hofhuis et al. BMC Public Health  (2016) 16:425 Page 4 of 6
from the tick monitoring program of Wageningen
University did not indicate a significant change in
Ixodes ricinus abundance in the Netherlands between
2009 and 2014. While erythema migrans is a clear
sign for a patient to seek medical care, most tick
bites do not require a GP’s attention. Whether people
decide to consult a physician for a tick bite, rather
than remove the tick themselves, may be influenced
by having tick bites frequently, public health educa-
tion and media attention.
Since the outcomes of the first GP survey on 1994 were
reported, the National Institute of Public Health and the
Environment of the Netherlands (RIVM), and Wagenin-
gen University, together with other stakeholders, have
prompted extensive national media attention on Lyme
borreliosis each year around springtime, with a national
awareness week on tick bites (www.weekvandeteek.nl) to
mark the onset of the tick bite season. The RIVM distrib-
uted annually updated campaign materials for public
health education of the general population on the preven-
tion of tick bites and Lyme borreliosis, and published a
national guideline for professionals on the prevention,
diagnosis, and treatment of Lyme borreliosis [30]. The
RIVM redesigned the campaign materials for public health
education of the general population in 2011, focussed on
skin checks and removing ticks - which the public per-
ceived most feasible [31], whereas previously the cam-
paign materials presented all possible evidence based
preventive measures. In 2012 the RIVM started ap-
proaching the public through social media, and with an
educational online video [32], and school-aged children
were targeted with an online serious game, teaching them
about ticks and Lyme borreliosis in a playful way [33]. In
2014 a mobile phone app on ticks and Lyme borreliosis
was launched. The effectivity of the educational online
video, online game and the mobile phone app are being
evaluated, to be published by Beaujean et al. Awaiting the
study outcomes on effectivity of public health education,
we tentatively propose that the decrease in GP consulta-
tions for tick bites may reflect the impact of repeated and
redesigned efforts of public health education about the
relevance of body checking and prompt tick removal and
when to visit a physician. Further monitoring and analysis
of the dynamics between humans and Ixodes ricinus
(infected with B. burgdorferi sensu lato), is required to
identify reasons for the currently observed change in trend
after 15 years of continuous increase of GP consultations
for tick bites and erythema migrans diagnoses in the
Netherlands.
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